$0.2444
0.0034[1.41%]
Last update: 12:46PM Get Real Time Here
Asensus Surgical
(AMEX:ASXC)Asensus Surgical Stock (AMEX:ASXC), Analyst Ratings, Price Targets, Predictions
Asensus Surgical Inc has a consensus price target of $0.17, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald on April 4, 2024, March 22, 2024, and November 16, 2023. With an average price target of $0.78 between HC Wainwright & Co., HC Wainwright & Co., and Cantor Fitzgerald, there's an implied 220.51% upside for Asensus Surgical Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Cantor Fitzgerald
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Asensus Surgical
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/04/2024 | ASXC | Buy Now | Asensus Surgical | $0.24 | 43.21% | HC Wainwright & Co. | Swayampakula Ramakanth | $2 → $0.35 | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2024 | ASXC | Buy Now | Asensus Surgical | $0.24 | 718.33% | HC Wainwright & Co. | Swayampakula Ramakanth | $2 → $2 | Maintains | Buy | Get Alert |
| 11/16/2023 | ASXC | Buy Now | Asensus Surgical | $0.24 | — | Cantor Fitzgerald | Ross Osborn | — | Downgrade | Overweight → Neutral | Get Alert |
| 11/15/2023 | ASXC | Buy Now | Asensus Surgical | $0.24 | 718.33% | HC Wainwright & Co. | Swayampakula Ramakanth | → $2 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2023 | ASXC | Buy Now | Asensus Surgical | $0.24 | 309.17% | Cantor Fitzgerald | Ross Osborn | → $1 | Reiterates | Overweight → Overweight | Get Alert |
| 08/11/2023 | ASXC | Buy Now | Asensus Surgical | $0.24 | 718.33% | HC Wainwright & Co. | Swayampakula Ramakanth | → $2 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | ASXC | Buy Now | Asensus Surgical | $0.24 | 718.33% | HC Wainwright & Co. | Swayampakula Ramakanth | → $2 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2023 | ASXC | Buy Now | Asensus Surgical | $0.24 | 718.33% | HC Wainwright & Co. | Swayampakula Ramakanth | $3 → $2 | Maintains | Buy | Get Alert |
| 02/22/2023 | ASXC | Buy Now | Asensus Surgical | $0.24 | 1127.5% | HC Wainwright & Co. | Swayampakula Ramakanth | → $3 | Reiterates | → Buy | Get Alert |
| 01/10/2023 | ASXC | Buy Now | Asensus Surgical | $0.24 | 1127.5% | HC Wainwright & Co. | Swayampakula Ramakanth | → $3 | Reiterates | → Buy | Get Alert |
| 09/08/2022 | ASXC | Buy Now | Asensus Surgical | $0.24 | 513.75% | Cantor Fitzgerald | Ross Osborn | → $1.5 | Initiates | → Overweight | Get Alert |
| 08/10/2022 | ASXC | Buy Now | Asensus Surgical | $0.24 | 1127.5% | HC Wainwright & Co. | Swayampakula Ramakanth | $4 → $3 | Maintains | Buy | Get Alert |
| 05/26/2021 | ASXC | Buy Now | Asensus Surgical | $0.24 | 1536.66% | HC Wainwright & Co. | Swayampakula Ramakanth | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Asensus Surgical (ASXC)?
The latest price target for Asensus Surgical (AMEX: ASXC) was reported by HC Wainwright & Co. on April 4, 2024. The analyst firm set a price target for $0.35 expecting ASXC to rise to within 12 months (a possible 43.21% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Asensus Surgical (ASXC)?
The latest analyst rating for Asensus Surgical (AMEX: ASXC) was provided by HC Wainwright & Co., and Asensus Surgical downgraded their neutral rating.
When was the last upgrade for Asensus Surgical (ASXC)?
There is no last upgrade for Asensus Surgical.
When was the last downgrade for Asensus Surgical (ASXC)?
The last downgrade for Asensus Surgical Inc happened on April 4, 2024 when HC Wainwright & Co. changed their price target from $2 to $0.35 for Asensus Surgical Inc.
When is the next analyst rating going to be posted or updated for Asensus Surgical (ASXC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Asensus Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Asensus Surgical was filed on April 4, 2024 so you should expect the next rating to be made available sometime around April 4, 2025.
Is the Analyst Rating Asensus Surgical (ASXC) correct?
While ratings are subjective and will change, the latest Asensus Surgical (ASXC) rating was a downgraded with a price target of $2.00 to $0.35. The current price Asensus Surgical (ASXC) is trading at is $0.24, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.